Cervical cancer and HPV vaccination: Knowledge and attitudes of adult women in Lusaka, Zambia

Journal of Vaccines and Vaccination

Volumn 3, Issue 3, 2012, Pages

  Liu, Fong W ^a   Vwalika, Bellington ^b,d   Hacker, Michele R ^a,c   Allen, Susan ^d   Awtrey, Christopher S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879805749     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.1000138     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF (2004) Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 109: 418-424.
3. Denny L, Quinn M, Sankaranarayanan R (2006) Chapter 8: Screening for cervical cancer in developing countries. Vaccine 24: S3/71-77.
4. Castellsagué X dSS, Aguado T, Louie KS, Bruni L, Muñoz J, et al. (2011) HPV and Cervical Cancer in the World. 2007 Report. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre).
5. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, et al. (2011) Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med 8: e1001032.
6. Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, et al. (2010) Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot 17: 47-50.
7. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, et al. (2006) Are women ready for the HPV vaccine? Gynecol Oncol 103: 151-154.
8. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI (2003) Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 14: 300-306.
9. McClelland A, Liamputtong P (2006) Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia. Sex Health 3: 95-101.
10. Giles M, Garland S (2006) A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. The Australian & New Zealand journal of obstetrics & gynaecology. 46: 311-315.
11. Moreira ED Jr., Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, et al. (2006) Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer 16: 599-603.
12. Donders GG, Gabrovska M, Bellen G, Van Keirsbilck J, Van Den Bosch T, et al. (2008) Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet 277: 291-298.
13. Brewer NT, Fazekas KI (2007) Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45:107-114.
14. Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF (2008) Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer 99: 225-229.
15. Gerend MA, Magloire ZF (2008) Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 42: 237-242.
16. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, et al. (2008) Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 111: 1103-1110.
17. Dinh TA, Rosenthal SL, Doan ED, Trang T, Pham VH, et al. (2007) Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health 40: 559-563.
18. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS (2010) HPV vaccine acceptability among Kenyan women. Vaccine 28: 4864-4867.
19. Harries J, Moodley J, Barone MA, Mall S, Sinanovic E (2009) Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine 27: 38-44.
20. Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, et al. (2008) An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health 12: 159-172.
21. Coleman MA, Levison J, Sangi-Haghpeykar H (2011) HPV vaccine acceptability in Ghana, West Africa. Vaccine 29: 3945-3950.
22. DiAngi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT (2011) A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PloS one 6: e25481.
23. UNICEF (2010) Information by Country: Zambia.
24. Goldie SJ, O'Shea M, Diaz M, Kim SY (2008) Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications. Reprod Health Matters 16: 86-96.
25. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, et al. (2008) Management of cryotherapy-ineligible women in a "screenand-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol 110: 402-407.
26. Zambia CfIDRi (2011) Cervical Cancer Screening Program.